Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017298
Filing Date
2019-05-08
Accepted
2019-05-08 16:58:44
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cue-10q_20190331.htm 10-Q 1239847
2 EX-31.1 cue-ex311_7.htm EX-31.1 18361
3 EX-31.2 cue-ex312_8.htm EX-31.2 18130
4 EX-32.1 cue-ex321_6.htm EX-32.1 11275
5 GRAPHIC g55ls1dg0ogi000002.jpg GRAPHIC 5865
6 GRAPHIC g55ls1dg0ogi000001.jpg GRAPHIC 37697
  Complete submission text file 0001564590-19-017298.txt   4750749

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cue-20190331.xml EX-101.INS 852955
8 XBRL TAXONOMY EXTENSION SCHEMA cue-20190331.xsd EX-101.SCH 48066
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20190331_cal.xml EX-101.CAL 39543
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20190331_def.xml EX-101.DEF 137725
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20190331_lab.xml EX-101.LAB 345513
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20190331_pre.xml EX-101.PRE 261553
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 19807445
SIC: 2834 Pharmaceutical Preparations